Recruiting NA Delirium

New treatment option for Delirium

Official title Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders

ClinicalTrials.gov ID: NCT05929703

What this study is testing

What it's testing
The goal of this clinical trial is to compare the Hospital Elder Life Program (HELP) with a family-augmented version of HELP (FAM-HELP), that includes family members and care partners, for the prevention of delirium in older patients during hospital admission. The main objectives of the trial are the following: 1.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 70 and older

You may be able to join if

  • Provision of informed consent
  • At least 70 years of age
  • Anticipated length of hospital stay at least 72 hours
  • Family member or care partner available to be on-site in the hospital
  • At least one delirium risk factor (e.g., cognitive or functional impairment, dehydration, vision or hearing impairment)

You likely can't join if

  • Delirium on admission
  • Unable to communicate verbally (e.g., coma, mechanical ventilation)
  • Unable to participate fully in interventions (e.g., terminal condition, advanced dementia)
  • Staff safety concerns (e.g., violent behavior)
  • Cardiac or intracranial surgery (due to competing causes of delirium)
See the full eligibility criteria
Who can join
  • Provision of informed consent
  • At least 70 years of age
  • Anticipated length of hospital stay at least 72 hours
  • Family member or care partner available to be on-site in the hospital
  • At least one delirium risk factor (e.g., cognitive or functional impairment, dehydration, vision or hearing impairment)
  • Evaluable cognitive function at baseline (i.e., ability to complete baseline cognitive function assessment)
What rules you out
  • Delirium on admission
  • Unable to communicate verbally (e.g., coma, mechanical ventilation)
  • Unable to participate fully in interventions (e.g., terminal condition, advanced dementia)
  • Staff safety concerns (e.g., violent behavior)
  • Cardiac or intracranial surgery (due to competing causes of delirium)

The study team makes the final eligibility decision.

Where it's taking place

  • Orange, California, United States
  • Portland, Maine, United States
  • Ann Arbor, Michigan, United States
  • Philadelphia, Pennsylvania, United States
  • Pittsburgh, Pennsylvania, United States
  • Salt Lake City, Utah, United States
  • Madison, Wisconsin, United States

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 70 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Orange, California, United States; Portland, Maine, United States; Ann Arbor, Michigan, United States; Philadelphia, Pennsylvania, United States; Pittsburgh, Pennsylvania, United States; Salt Lake City, Utah, United States and 1 more location(s). Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.